Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEATLE: Extended Infusion of β-lactam Antibiotics for Febrile Neutropenia
NCT04233996Phase 4Unknown
- Sponsor
- Bellvitge University Hospital
- Start
- Jun 2019
- Primary completion
- Dec 2021
- Modality
- Irreversible Covalent Inhibitors, Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of piperacillin + tazobactam, cefepime, meropenem in febrile neutropenia (FN), sponsored by Bellvitge University Hospital. Status: unknown.
02
Drugs
piperacillin + tazobactamcefepimemeropenem
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT04233996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04233996.